Ardelyx | ARDX - Gross Profit On Sales

Stock Price
6.54
Daily Change
-0.10 -1.43%
Monthly
-17.17%
Yearly
25.19%
Q1 Forecast
5.55

Ardelyx reported $106.35M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.54B 625M Dec/2025
Amgen USD 6.48B 307M Sep/2025
Ardelyx USD 106.35M 23.51M Sep/2025
aTyr Pharma USD 190K 15.57M Sep/2025
Corcept Therapeutics USD 199.58M 3.46M Dec/2025
Curis USD -7.72M 140K Jun/2024
Sanofi EUR 8.45B 3.02B Dec/2025
TG Therapeutics USD 154.43M 20.81M Dec/2025
United Therapeutics USD 315.5M 286.6M Dec/2025
Xoma 992K 846K Jun/2024